Hofer, T.P. et al. Early recovery of leukocyte subsets is associated with favorable progression-free survival in patients with inoperable stage II/III NSCLC after multimodal treatment: A prospective explorative study. Radiat. Oncol. 20:43 (2025)
Vorbach, S.M.* et al. Stereotactic body radiotherapy for single and multiple early-stage non-small cell lung cancer in patients aged ≥ 80 years. Radiat. Oncol. 20:113 (2025)
Kraus, K.M. et al. Pneumonitis after normofractionated radioimmunotherapy: A method for dosimetric evaluation. Radiat. Oncol. 19:169 (2024)
Moser, R.* et al. A survey of cancer patients' interest in undertaking exercise to promote relaxation during radiotherapy for breast cancer and metastatic cancer. Radiat. Oncol. 19:68 (2024)
Schwab, M.* et al. The radiation- and chemo-sensitizing capacity of diclofenac can be predicted by a decreased lactate metabolism and stress response. Radiat. Oncol. 19:7 (2024)
Dapper, H.* et al. Outcome of patients with soft tissue sarcomas of the extremities and trunk treated by (neo)adjuvant intensity modulated radiation therapy with curative intent. Radiat. Oncol. 18:44 (2023)
Schnöller, L.E.* et al. Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data. Radiat. Oncol. 18:51 (2023)
Borm, K.J.* et al. Comparison of the distribution of lymph node metastases compared to healthy lymph nodes in breast cancer. Radiat. Oncol. 17:27 (2022)
Schnöller, L.E.* et al. Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy. Radiat. Oncol. 17:79 (2022)
Corradini, S.* et al. X-change symposium: Status and future of modern radiation oncology-from technology to biology. Radiat. Oncol. 16:27 (2021)
Mei, J.* et al. Development of a model for fibroblast-led collective migration from breast cancer cell spheroids to study radiation effects on invasiveness. Radiat. Oncol. 16:159 (2021)
Niu, M.* et al. Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: A multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiat. Oncol. 16:141 (2021)
Vogel, M.M. et al. A survey among German-speaking radiation oncologists on PET-based radiotherapy of prostate cancer. Radiat. Oncol. 16:82 (2021)
Brix, N.* et al. The clonogenic assay: Robustness of plating efficiency-based analysis is strongly compromised by cellular cooperation. Radiat. Oncol. 15:248 (2020)
Combs, S.E. et al. First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments. Radiat. Oncol. 15:74 (2020)
Gaasch, A.* et al. Heart sparing radiotherapy in breast cancer: The importance of baseline cardiac risks. Radiat. Oncol. 15:117 (2020)
Käsmann, L.* et al. Radiation-induced lung toxicity - cellular and molecular mechanisms of pathogenesis, management, and literature review. Radiat. Oncol. 15:214 (2020)
Pigorsch, S.U.* et al. Report on planning comparison of VMAT, IMRT and helical tomotherapy for the ESCALOX-trial pre-study. Radiat. Oncol. 15:253 (2020)
Samaga, D. et al. Single-center versus multi-center data sets for molecular prognostic modeling: A simulation study. Radiat. Oncol. 15:109 (2020)
Scharl, S.* et al. Is local radiotherapy a viable option for patients with an opening of the ventricles during surgical resection of brain metastases? Radiat. Oncol. 15:276 (2020)
Schaule, J.* et al. Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8). Radiat. Oncol. 15:280 (2020)
Schaule, J.* et al. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy Melanoma brain metastases prognostic score. Radiat. Oncol. 15:135 (2020)
Schüttrumpf, L. et al. Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck-results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer". Radiat. Oncol. 15:7 (2020)
Selmansberger, M. et al. Transcriptome network of the papillary thyroid carcinoma radiation marker CLIP2. Radiat. Oncol. 15:182 (2020)
Simonetto, C. et al. Longitudinal atherosclerotic changes after radio(chemo)therapy of hypopharyngeal carcinoma. Radiat. Oncol. 15:102 (2020)
Stegen, B.* et al. Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: A proof-of-concept study. Radiat. Oncol. 15:19 (2020)
Straube, C.* et al. A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma. Radiat. Oncol. 15:97 (2020)
Duma, M.N.* et al. Positive correlation between blood glucose and radiotherapy doses to the central gustatory system in Glioblastoma Multiforme patients. Radiat. Oncol. 14:97 (2019)
Mayinger, M.* et al. Incidental dose distribution to locoregional lymph nodes of breast cancer patients undergoing adjuvant radiotherapy with tomotherapy - is it time to adjust current contouring guidelines to the radiation technique? Radiat. Oncol. 14:135 (2019)
Mayinger, M.* et al. MRI based neuroanatomical segmentation in breast cancer patients: Leptomeningeal carcinomatosis vs. oligometastatic brain disease vs. multimetastastic brain disease. Radiat. Oncol. 14:170 (2019)
Münch, S.* et al. Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus. Radiat. Oncol. 14:66 (2019)
Oechsner, M.* et al. Deep inspiration breath-hold for left-sided breast irradiation: Analysis of dose-mass histograms and the impact of lung expansion. Radiat. Oncol. 14:109 (2019)
Peeken, J.C.* et al. Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experience. Radiat. Oncol. 14:2 (2019)
Rothammer, A.* ; Sage, E.K.* ; Werner, C.* ; Combs, S.E. & Multhoff, G.* Increased heat shock protein 70 (Hsp70) serum levels and low NK cell counts after radiotherapy - potential markers for predicting breast cancer recurrence? Radiat. Oncol. 14:78 (2019)
Vogel, M.M. et al. Adjuvant versus early salvage radiotherapy: outcome of patients with prostate cancer treated with postoperative radiotherapy after radical prostatectomy. Radiat. Oncol. 14:198 (2019)
Borm, K.J.* et al. Acute radiodermatitis in modern adjuvant 3D conformal radiotherapy for breast cancer - the impact of dose distribution and patient related factors. Radiat. Oncol. 13:218 (2018)
Dapper, H.* et al. Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer. Radiat. Oncol. 13:169 (2018)
Dapper, H.* et al. Dosimetric comparison of different radiation techniques (IMRT vs. 3-dimensional) of the "true" (deep) ano-inguinal lymphatic drainage of anal cancer patients. Radiat. Oncol. 13, 227 (2018)
Dapper, H.* et al. Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer. Radiat. Oncol. 13:237 (2018)
Dreher, C.* et al. Evaluation of the tumor movement and the reproducibility of two different immobilization setups for image-guided stereotactic body radiotherapy of liver tumors. Radiat. Oncol. 13:15 (2018)
El Shafie, R.A.* et al. Clinical outcome after particle therapy for meningiomas of the skull base: Toxicity and local control in patients treated with active rasterscanning. Radiat. Oncol. 13:54 (2018)
El Shafie, R.A.* et al. Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma. Radiat. Oncol. 13:86 (2018)
Grote, M.* ; Maihöfer, C. ; Weigl, M.* ; Davies-Knorr, P.* & Belka, C. Progressive resistance training in cachectic head and neck cancer patients undergoing radiotherapy: A randomized controlled pilot feasibility trial. Radiat. Oncol. 13:215 (2018)
Ilicic, K. ; Combs, S.E. & Schmid, T.E. New insights in the relative radiobiological effectiveness of proton irradiation. Radiat. Oncol. 13:6 (2018)
Krauze, A.V.* et al. Correction to expert consensus on re-irradiation for recurrent glioma. Radiat. Oncol. 13:8 (2018)
Maihoefer, C. et al. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer". Radiat. Oncol. 13:123 (2018)
Münch, S.* et al. Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus. Radiat. Oncol. 13:182 (2018)
Schiller, K.* et al. Impact of68Ga-PSMA-PET imaging on target volume definition and guidelines in radiation oncology - a patterns of failure analysis in patients with primary diagnosis of prostate cancer. Radiat. Oncol. 13:36 (2018)
Stade, F.* et al. Influence of68Ga-DOTATOC on sparing of normal tissue for radiation therapy of skull base meningioma: Differential impact of photon and proton radiotherapy. Radiat. Oncol. 13:58 (2018)
Straube, C.* et al. Dosimetric impact of tumor treating field (TTField) transducer arrays onto treatment plans for glioblastomas - a planning study. Radiat. Oncol. 13:31 (2018)
Zschaeck, S.* et al. PSMA-PET based radiotherapy: A review of initial experiences, survey on current practice and future perspectives. Radiat. Oncol. 13:90 (2018)
Dittmar, J.O.* et al. First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas. Radiat. Oncol. 12:169 (2017)
Dreher, C.* ; Habermehl, D. ; Jäkel, O.* & Combs, S.E. Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: Higher doses alone, higher RBE or both? Radiat. Oncol. 12:203 (2017)
Duma, M.N. et al. Helical TomoTherapy for locally advanced or recurrent breast cancer. Radiat. Oncol. 12:31 (2017)
Hegemann, N.S.* et al. Risk of second cancer following radiotherapy for prostate cancer: A population-based analysis. Radiat. Oncol. 12:2 (2017)
Krauze, A.* et al. Expert consensus on re-irradiation for recurrent glioma. Radiat. Oncol. 12:194 (2017)
Münch, S.* et al. Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus. Radiat. Oncol. 12:182 (2017)
Münch, S.* ; Oechsner, M.* ; Combs, S.E. & Habermehl, D. DVH- and NTCP-based dosimetric comparison of different longitudinal margins for VMAT-IMRT of esophageal cancer. Radiat. Oncol. 12:128 (2017)
Pigorsch, S.U. et al. Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol. Radiat. Oncol. 12:45 (2017)
Straube, C.* et al. Does age really matter? Radiotherapy in elderly patients with glioblastoma, the Munich experience. Radiat. Oncol. 12:77 (2017)
Michna, A. et al. Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: Time-course gene expression profiles and gene association networks. Radiat. Oncol. 11:94 (2016)
Oechsner, M.* et al. Registration uncertainties between 3D cone beam computed tomography and different reference CT datasets in lung stereotactic body radiation therapy. Radiat. Oncol. 11:142 (2016)
Straube, C.* et al. Reduced volume SIB-IMRT/IGRT to head and neck cancer in elderly and frail patients: Outcome and toxicity. Radiat. Oncol. 11:133 (2016)
Unkel, S.* ; Belka, C. & Lauber, K. On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model. Radiat. Oncol. 11:11 (2016)
Braselmann, H. ; Michna, A. ; Hess J. & Unger, K. CFAssay: Statistical analysis of the colony formation assay. Radiat. Oncol. 10:223 (2015)
Kessel, K.A. & Combs, S.E. Data management, documentation and analysis systems in radiation oncology: A multi-institutional survey. Radiat. Oncol. 10:230 (2015)
Murakami, N.* et al. Role of membrane Hsp70 in radiation sensitivity of tumor cells. Radiat. Oncol. 10:149 (2015)
Oechsner, M.* et al. Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy. Radiat. Oncol. 10:249 (2015)
Summerer, I. et al. Erratum: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients. Radiat. Oncol. 10:102 (2015)
Wohlleben, G.* et al. Influence of hypoxia and irradiation on osteopontin expression in head and neck cancer and glioblastoma cell lines. Radiat. Oncol. 10:167 (2015)
Gehrmann, M.* et al. Hsp70 - a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck. Radiat. Oncol. 9:131 (2014)
Maroschik, B.* et al. Radiation-induced alterations of histone post-translational modification levels in lymphoblastoid cell lines. Radiat. Oncol. 9:15 (2014)
Unger, K. Integrative radiation systems biology. Radiat. Oncol. 9:21 (2014)
Summerer, I. et al. Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients. Radiat. Oncol. 8:296 (2013)
Anastasov, N. et al. Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells. Radiat. Oncol. 7:206 (2012)
Garny, S. ; Rühm, W. ; Zankl, M. ; Wagner, F.M.* & Paretzke, H.G. First steps towards a fast-neutron therapy planning program. Radiat. Oncol. 6:163 (2011)
Huber, R. et al. Chromosomal radiosensitivity and acute radiation side effects after radiotherapy in tumour patients - a follow-up study. Radiat. Oncol. 6:32 (2011)
Niyazi, M.* et al. MiRNA expression patterns predict survival in glioblastoma. Radiat. Oncol. 6:153 (2011)
Henke, G.* et al. Pharmacokinetics and biodistribution of Erufosine in nude mice - implications for combination with radiotherapy. Radiat. Oncol. 4:46 (2009)